Erythromycin and Valproate Interaction
Ann Int Med 116:877-878, Redington,K.,et al, 1992
Comparison of Sprinkle Versus Syrup Formulations of Valproate for Bioavailability, Tolerance, and Preference
J Pediatr 120:634-638, Cloyd,J.C.,et al, 1992
Juvenile Myoclonic Epilepsy, Underdiagnosed and Treatment May Have to be Life Long
BMJ 305:4-5, Timmings,P.L.&Richens,A., 1992
Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992
Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992
Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Evoked Potentials in Cerebrotendinous Xanthomatosis and Effect Induced by Chenodeoxycholic Acid
Arch Neurol 49:469-475, Mondelli,M.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
Clinicopath Conf
Infantile Striatonigral Regeneration, with Cerebellar Degeneration, Familial, Case 30-1992, NEJM 327, 261-1992., 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Low Cerebrospinal Fluid Concentration of Free Gamma-Aminobutyric Acid in Startle Disease
Lancet 340:80-81, Dubowitz,L.M.S.,et al, 1992
Cluster Headache
Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992
Pharmacologic Treatment of Childhood Migraine
J Pediatr 120:653-657, Ingarashi,M.,et al, 1992
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
Acute and Persistent Parkinsonism after Use of Diquat
Neurol 42:261-263, Sechi,G.P.,et al, 1992
Surgical Management of Spastic Diplegia in Cerebral Palsy
NEJM 326:745-749, Park,T.S.&Owen,J.H., 1992
Delay in P300 Latency in Patients with Organic Solvent Exposure
Arch Neurol 49:315-320, Morrow,L.A.,et al, 1992
Eosinophilic Meningitis Due to Angiostrongylus Cantonensis
Neurol 42:1423-1424, Noskin,G.A.,et al, 1992
Bacterial Meningitis in Children:Pathophysiology and Treatment
Neurol 42:739-748, Ashwal,S.,et al, 1992
Environmental Exposure to Lead & Children's Intelligence at Age 7 Years
NEJM 327:1279-1284, 13081992., Baghurst,P.A.,et al, 1992
Low-Level Lead Exposure, Intelligence and Academic Achievement:A Long-Term Follow-Up Study
Pediatrics 90:855-861, Bellinger,D.C.,et al, 1992
Neurocognitive Effects of Aluminum
Arch Neurol 49:1021-1026, Bolla,K.I.,et al, 1992
Orthostatic Hypotension in Ciguatera Fish Poisoning
Arch Int Med 152:2131-2133, Geller,R.J.&Banowitz,N.L., 1992
Travel and Ciguatera Fish Poisoning
Arch Int Med 152:2049-2053, Lange,W.R.,et al, 1992
Cognitive Development of Yu-Cheng ('Oil Disease') Children Prenatally Exposed to Heat-Degraded PCBs
JAMA 268:3213-3218, Chen,Y.J.,et al, 1992
Lesions of Basal Ganglia Due to Disulfiram Neurotoxicity
JNNP 55:925-929, Laplane,D.,et al, 1992
Typical Absence Seizures in Adults:Clinical, EEG, Video-EEG Findings & Diagnostic/Syndr Consider
JNNP 55:1002-1008, Panayiotopoulos,C.P.,et al, 1992
Safety and Efficacy of Valproate and Carbamazepine in the Treatment of Complex Partial Seizures
J Epilepsy 5:149-152, So,E.L.,et al, 1992
Delayed Diagnosis of Juvenile Myoclonic Epilepsy
JNNP 55:497-499, Grunewald,R.A.,et al, 1992
Prevention of First Occur of Neural-Tube Defects by Periconceptional Vitamin Suppl
NEJM 327:1832-1835, 18751992., Czeizel,A.E.&Dudas,I., 1992
Early Childhood Hepatocerebral Degeneration Misdiagnosed as Valproate Hepatotoxicity
Ann Neurol 32:767-775, Bicknese,A.R.,et al, 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992
Prolonged Seizure Activity after Baclofen Withdrawal
Neurol 42:697-698, Kofler,M.&Leis,A.A., 1992
Unsuspected, Surreptitious Drug-Induced Parkinsonism
Neurol 42:459, Albanese,A.,et al, 1992
Erythromelalgia:Review of Clinical Characteristics and Pathophysiology
Am J Med 91:416-422, Jurzrock,R.&Cohen,P.R., 1991
Migraine-Related Stroke in Childhood
Lancet 337:825-826, , 1991
N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991
Mitochondrial Dysfunction in Multiple Symmetrical Lipomatosis
Ann Neurol 29:566-569, Berkovic,S.F.,et al, 1991
Prevention of Neural Tube Defects:Results of the Medical Research Council Vitamin Study
Lancet 338:131-137, 153-1541991., , 1991
The Effect of Valproic Acid on Plasma Carnitine Levels
Am J Dis Child 145:9999-1001, Opala,G.,et al, 1991
Muscle Carnitine Deficiency in Patients Using Valproic Acid
J Pediatr 118:646-649, Shapira,Y.&Gutman,A., 1991
Stroke Prevention in Women:role of Aspirin Versus Ticlopidine
Am J Med 91:288-292, Hershey,L.A., 1991
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991